Pediatric obesity management: variation by specialty and awareness of guidelines

Erinn T Rhodes1, Cara B Ebbeling, Alan F Meyers

  • 1Division of Endocrinology, Children's Hospital Boston, Boston, Massachusetts 02115, USA. erinn.rhodes@childrens.harvard.edu

Clinical Pediatrics
|June 21, 2007
PubMed

Insights

Pediatric specialists show varying awareness of obesity guidelines. Differences in managing pediatric overweight exist between specialists and family practice providers, impacting care quality.

Area of Science:

  • Pediatric Endocrinology
  • General Pediatrics
  • Family Medicine

Background:

  • Pediatric overweight and obesity are significant public health concerns.
  • Effective management requires adherence to evidence-based guidelines.
  • Awareness and implementation of Expert Committee Recommendations (ECR) among clinicians are crucial for optimal care.

Purpose of the Study:

  • To assess pediatric clinicians' awareness of ECR for obesity.
  • To evaluate current practices in pediatric overweight management.
  • To identify differences in awareness and management between pediatric specialists (PS) and family practice specialists (FPS).

Main Methods:

  • A survey was distributed to 2727 pediatric clinicians.
  • Response rate was 45%, with data analyzed for awareness of ECR and management practices.
  • Statistical analysis included odds ratios (OR) and 95% confidence intervals (CI) to compare groups.

Main Results:

  • Only 24.6% of clinicians were aware of ECR.
  • FPS were less aware of ECR than PS (OR, 0.46).
  • Significant differences were observed in Body Mass Index (BMI) use, laboratory testing, and follow-up frequency between PS and FPS.
  • ECR awareness correlated with better management practices among PS but not FPS.

Conclusions:

  • There are significant disparities in ECR awareness and pediatric overweight management practices between PS and FPS.
  • Current guidelines may not be effectively reaching or being implemented by all pediatric care providers.
  • Future guidelines and educational initiatives should address these specialty-specific differences to improve pediatric obesity care.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...